Platelet Transfusions Help Address Bleeding Risk in Cancer Patients
Blood transfusions are an indispensable component of healthcare. They contribute to saving millions of lives each year and can dramatically improve the life expectancy and quality of life of patients. Bleeding is a common problem in cancer patients due to the disease itself or to anti-cancer treatments. The use of platelet transfusions to mitigate bleeding risk due to cancer or cancer-related treatments has been shown to improve patient outcomes. The South African National Blood Service (SANBS) offers the crucial service of providing a safe and sufficient supply of blood products for those requiring transfusions.
Modern Medicine – Issue 4, 2025